Bayer buys BlueRock in USD 600 million bet on stem cell therapies Medical Dialogues Bureau9 Aug 2019 3:30 AM GMTFRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...
Pfizer, GSK completes transaction to form new consumer healthcare JV Medical Dialogues Bureau3 Aug 2019 4:10 AM GMTThe Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
GSK, Pfizer gets CCI approval for consumer healthcare JV formation Garima25 May 2019 4:15 AM GMTAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
Suven Life Sciences enters asset purchase agreement with Rising Pharma Garima10 March 2019 5:30 AM GMTSuven Life Sciences through its joint venture partner, Shore Suven Pharma, Inc has entered into a "stalking horse" asset purchase agreement to buy the...
Max India in talks to buyout partner in Max Healthcare Ruby Khatun Khatun10 April 2018 10:34 AM GMTNew Delhi: Max India on Monday said its board will consider buying out its equal partner in the healthcare business, Life Healthcare Group Holdings,...
Magma HDI forays into health insurance with OneHealth policy Ruby Khatun Khatun2 Dec 2017 4:15 AM GMTNew Delhi: Non-banking finance company Magma Fincorp has forayed into health insurance business through its joint-venture Magma HDI General Insurance...
AstraZeneca steps up China push with new drug joint venture Ruby Khatun Khatun28 Nov 2017 8:20 AM GMTLONDON: Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a...
Granules India gets EIR from USFDA for Vizag OmniChem facility Ruby Khatun Khatun8 Oct 2017 4:31 AM GMTNew Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility...
